FR11C0020I1 - - Google Patents
Info
- Publication number
- FR11C0020I1 FR11C0020I1 FR11C0020C FR11C0020I1 FR 11C0020 I1 FR11C0020 I1 FR 11C0020I1 FR 11C0020 C FR11C0020 C FR 11C0020C FR 11C0020 I1 FR11C0020 I1 FR 11C0020I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34861496 | 1996-12-26 | ||
JP7405497 | 1997-03-26 | ||
JP17247797 | 1997-06-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR11C0020I1 true FR11C0020I1 (en) | 2011-07-29 |
FR11C0020I2 FR11C0020I2 (en) | 2012-03-16 |
Family
ID=27301396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR11C0020C Active FR11C0020I2 (en) | 1996-12-26 | 2011-06-21 | Difluoroprostaglandin derivatives and their application |
Country Status (16)
Country | Link |
---|---|
US (2) | US5886035A (en) |
EP (1) | EP0850926B1 (en) |
JP (2) | JP3480549B2 (en) |
KR (1) | KR100526282B1 (en) |
CN (1) | CN1108289C (en) |
AT (1) | ATE225770T1 (en) |
CA (1) | CA2225761C (en) |
DE (2) | DE122008000050I2 (en) |
DK (1) | DK0850926T3 (en) |
ES (1) | ES2187719T3 (en) |
FR (1) | FR11C0020I2 (en) |
LU (1) | LU91943I2 (en) |
NL (1) | NL300407I2 (en) |
NO (2) | NO317060B1 (en) |
PT (1) | PT850926E (en) |
TW (1) | TW536534B (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0930296B2 (en) * | 1996-09-17 | 2005-11-02 | Asahi Glass Company Ltd. | Fluorinated prostaglandin derivatives and medicines |
US6225348B1 (en) | 1998-08-20 | 2001-05-01 | Alfred W. Paulsen | Method of treating macular degeneration with a prostaglandin derivative |
IL134241A (en) * | 2000-01-27 | 2006-06-11 | Finetech Pharmaceutical Ltd | Process for the preparation of latanoprost |
IL143477A (en) | 2001-05-31 | 2009-07-20 | Finetech Pharmaceutical Ltd | Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives |
AU2001228836A1 (en) * | 2000-01-28 | 2001-08-07 | Santen Pharmaceutical Co., Ltd. | Novel difluoroprostaglandin derivative |
ATE490761T1 (en) * | 2000-09-13 | 2010-12-15 | Santen Pharmaceutical Co Ltd | EYE DROP |
DE60316574T2 (en) * | 2002-08-23 | 2008-07-03 | Santen Pharmaceutical Co., Ltd | STABLE EYE DROPS CONTAINING LATANOPROST AS AN ACTIVE SUBSTANCE |
AU2003261981A1 (en) | 2002-09-09 | 2004-03-29 | Santen Pharmaceutical Co., Ltd. | Transparent eye drops containing latanoprost |
WO2005011704A1 (en) * | 2003-07-31 | 2005-02-10 | Santen Pharmaceutical Co., Ltd. | Product containing prostaglandin |
CN102394895A (en) * | 2003-12-08 | 2012-03-28 | 高通股份有限公司 | High data rate interface with improved link synchronization |
CN101072568A (en) * | 2004-12-09 | 2007-11-14 | 参天制药株式会社 | Product containing prostaglandin having fluorine atom in molecule |
JP4753178B2 (en) * | 2004-12-24 | 2011-08-24 | 参天製薬株式会社 | Products containing prostaglandin F2α derivatives |
JP5100025B2 (en) * | 2005-03-31 | 2012-12-19 | 旭硝子株式会社 | Retinal nerve cell protective agent containing prostaglandin F2α derivative as an active ingredient |
KR101396731B1 (en) * | 2005-03-31 | 2014-05-19 | 산텐 세이야꾸 가부시키가이샤 | PROTECTIVE AGENT FOR RETINAL NEURONAL CELL CONTAINING PROSTAGLANDIN F2α DERIVATIVE AS ACTIVE INGREDIENT |
JPWO2006112313A1 (en) | 2005-04-13 | 2008-12-11 | 宇部興産株式会社 | Retinal nerve cell protective agent containing an indazole derivative as an active ingredient |
WO2007000642A1 (en) * | 2005-06-29 | 2007-01-04 | Pfizer Inc. | Fluoroprostaglandins nitroderivatives |
JP4851467B2 (en) * | 2006-02-07 | 2012-01-11 | 株式会社アールテック・ウエノ | Method for producing prostaglandin derivatives |
WO2007111806A2 (en) | 2006-03-23 | 2007-10-04 | Massachusetts Eye And Ear Infirmary | Cyclopentane heptanoic acid compounds for reducing body fat |
FR2918891B1 (en) * | 2007-07-20 | 2009-09-25 | Thea Sa Lab | OPHTHALMIC SOLUTION BASED ON PROSTAGLANDINS WITHOUT PRESERVATIVE |
EP2127638A1 (en) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
CA2735825C (en) * | 2008-09-04 | 2016-06-21 | Santen Pharmaceutical Co., Ltd. | Hair growth promoting agent containing 15,15-difluoroprostaglandin f2.alpha. derivative as active ingredient |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
CA2807301C (en) | 2010-08-02 | 2018-11-27 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
ES2579990T3 (en) | 2011-01-19 | 2016-08-18 | Terakine Therapeutics, Inc. | Methods and compositions to treat metabolic syndrome |
TW201729813A (en) | 2011-02-04 | 2017-09-01 | Kowa Co Ltd | Drug therapy for preventing or treating glaucoma |
US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
US20150011755A1 (en) * | 2012-02-07 | 2015-01-08 | Dr. Reddys Laboratories Limited | Amine salts of prostaglandin analogs |
CA2874288A1 (en) | 2012-05-30 | 2013-12-05 | Asahi Glass Company, Limited | Composition for hair growth |
MX2015006390A (en) | 2012-11-21 | 2015-08-05 | Topokine Therapeutics Inc | Methods and compositions for locally increasing body fat. |
NO2753788T3 (en) | 2013-05-10 | 2018-06-16 | ||
US9820993B2 (en) | 2013-05-15 | 2017-11-21 | Topokine Therapeutics, Inc. | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat |
CN103570549B (en) * | 2013-10-11 | 2016-01-27 | 天泽恩源(天津)制药有限公司 | A kind of method of synthesizing tafluprost |
CN103804195B (en) * | 2014-01-26 | 2016-06-15 | 天泽恩源(天津)制药有限公司 | A kind of method synthesizing tafluprost |
CN103819436A (en) * | 2014-02-21 | 2014-05-28 | 天泽恩源(天津)医药技术有限公司 | Crystal form of (3aR,4R,5R,6aS)-4-((E)-3,3-difluoro-4-phenoxylbutyl-1-alkyl-1-yl)-2-oxohexahydro-2H-cyclopentane[b]furan-5-benzoate, and preparation method of corresponding crystals thereof |
US10188661B2 (en) | 2014-06-27 | 2019-01-29 | Topokine Therapeutics, Inc. | Topical dosage regimen |
KR20160116402A (en) | 2015-03-30 | 2016-10-10 | 연성정밀화학(주) | Process for Preparing Tafluprost |
MA42953A (en) | 2015-09-22 | 2018-08-01 | Graybug Vision Inc | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS |
CN107226790A (en) * | 2016-03-25 | 2017-10-03 | 苏州朗科生物技术有限公司 | A kind of preparation method and midbody compound of high-purity tafluprost and its similar compound |
GR1009040B (en) | 2016-04-19 | 2017-05-19 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Preservative free pharmaceutical ophthalmic compositions |
WO2018033854A1 (en) | 2016-08-15 | 2018-02-22 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition and a method for treating ocular hypertension and glaucoma |
CN108299192A (en) * | 2017-01-10 | 2018-07-20 | 江苏恒瑞医药股份有限公司 | A kind of metal salt compound crystal form and preparation method thereof of tafluprost acid |
CN106986766B (en) * | 2017-05-08 | 2021-01-12 | 扬子江药业集团有限公司 | Preparation method of tafluprost |
CN112457277B (en) * | 2020-12-16 | 2022-06-28 | 西安国康瑞金制药有限公司 | Preparation method of tafluprost |
CN112851510B (en) * | 2021-01-27 | 2022-07-19 | Agc株式会社 | Purification method of tafluprost |
CN112832150B (en) * | 2021-01-27 | 2022-06-24 | 中交第三公路工程局有限公司 | Vertical scabbling device for equal vertical surfaces of culvert channels |
CN116120268A (en) * | 2023-03-06 | 2023-05-16 | 南京华威医药科技集团有限公司 | Tafluprost intermediate impurity and preparation method thereof |
CN116425707A (en) * | 2023-03-31 | 2023-07-14 | 南京华威医药科技集团有限公司 | Tafluprost intermediate isomer impurity and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166178B1 (en) * | 1987-09-18 | 1998-07-21 | R Tech Ueno Ltd | Ocular hypotensive agents |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
JPH0770054A (en) * | 1993-08-30 | 1995-03-14 | R Tec Ueno:Kk | Biological antagonist and disease-treating preparation |
EP0930296B2 (en) * | 1996-09-17 | 2005-11-02 | Asahi Glass Company Ltd. | Fluorinated prostaglandin derivatives and medicines |
WO1998021181A2 (en) * | 1996-11-12 | 1998-05-22 | Alcon Laboratories, Inc. | 15-fluoro prostaglandins as ocular hypotensives |
-
1997
- 1997-12-12 JP JP34334397A patent/JP3480549B2/en not_active Expired - Lifetime
- 1997-12-17 TW TW086119094A patent/TW536534B/en not_active IP Right Cessation
- 1997-12-18 US US08/993,017 patent/US5886035A/en not_active Expired - Lifetime
- 1997-12-22 PT PT97122702T patent/PT850926E/en unknown
- 1997-12-22 EP EP97122702A patent/EP0850926B1/en not_active Expired - Lifetime
- 1997-12-22 DE DE122008000050C patent/DE122008000050I2/en active Active
- 1997-12-22 AT AT97122702T patent/ATE225770T1/en active
- 1997-12-22 ES ES97122702T patent/ES2187719T3/en not_active Expired - Lifetime
- 1997-12-22 DK DK97122702T patent/DK0850926T3/en active
- 1997-12-22 DE DE69716226T patent/DE69716226T2/en not_active Expired - Lifetime
- 1997-12-23 CA CA002225761A patent/CA2225761C/en not_active Expired - Lifetime
- 1997-12-23 NO NO19976085A patent/NO317060B1/en not_active IP Right Cessation
- 1997-12-26 CN CN97126331A patent/CN1108289C/en not_active Expired - Lifetime
- 1997-12-26 KR KR1019970074620A patent/KR100526282B1/en not_active IP Right Cessation
-
1998
- 1998-08-03 US US09/127,804 patent/US5985920A/en not_active Expired - Lifetime
-
2003
- 2003-07-31 JP JP2003284134A patent/JP3994074B2/en not_active Expired - Lifetime
-
2009
- 2009-03-06 NO NO2009006C patent/NO2009006I2/en not_active IP Right Cessation
- 2009-09-02 NL NL300407C patent/NL300407I2/en unknown
-
2011
- 2011-06-21 FR FR11C0020C patent/FR11C0020I2/en active Active
-
2012
- 2012-02-15 LU LU91943C patent/LU91943I2/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO2009006I1 (en) | 2009-03-16 |
FR11C0020I2 (en) | 2012-03-16 |
DE122008000050I2 (en) | 2011-06-16 |
ATE225770T1 (en) | 2002-10-15 |
CA2225761A1 (en) | 1998-06-26 |
JP3994074B2 (en) | 2007-10-17 |
NO976085L (en) | 1998-06-29 |
EP0850926A2 (en) | 1998-07-01 |
TW536534B (en) | 2003-06-11 |
NO2009006I2 (en) | 2012-03-05 |
EP0850926A3 (en) | 1999-06-16 |
DE69716226T2 (en) | 2003-06-05 |
EP0850926B1 (en) | 2002-10-09 |
JP2004002462A (en) | 2004-01-08 |
DE122008000050I1 (en) | 2009-01-29 |
LU91943I2 (en) | 2012-04-16 |
NO317060B1 (en) | 2004-08-02 |
CA2225761C (en) | 2009-04-21 |
CN1187486A (en) | 1998-07-15 |
ES2187719T3 (en) | 2003-06-16 |
NO976085D0 (en) | 1997-12-23 |
CN1108289C (en) | 2003-05-14 |
US5886035A (en) | 1999-03-23 |
NL300407I2 (en) | 2010-03-01 |
PT850926E (en) | 2003-02-28 |
DK0850926T3 (en) | 2003-02-17 |
DE69716226D1 (en) | 2002-11-14 |
KR100526282B1 (en) | 2006-05-17 |
KR19980064718A (en) | 1998-10-07 |
US5985920A (en) | 1999-11-16 |
JPH1171344A (en) | 1999-03-16 |
NL300407I1 (en) | 2009-11-02 |
JP3480549B2 (en) | 2003-12-22 |